Literature DB >> 28500586

Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation.

Ilaria Lenci1, Alessandra Bosa2, Martina Milana2, Leonardo Baiocchi2, Francesco Paolo Antonucci3, Marianna Aragri3, Francesca Ceccherini-Silberstein3, Carlo Federico Perno3, Giuseppe Tisone4, Mario Angelico2.   

Abstract

Entities:  

Keywords:  DAA treatment; HCV eradication; Liver transplantation

Mesh：

Substances：

Year:  2017        PMID： 28500586     DOI： 10.1007/s10620-017-4594-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

1.  Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.

Authors:  Michael P Curry; Xavier Forns; Raymond T Chung; Norah A Terrault; Robert Brown; Jonathan M Fenkel; Fredric Gordon; Jacqueline O'Leary; Alexander Kuo; Thomas Schiano; Gregory Everson; Eugene Schiff; Alex Befeler; Edward Gane; Sammy Saab; John G McHutchison; G Mani Subramanian; William T Symonds; Jill Denning; Lindsay McNair; Sarah Arterburn; Evguenia Svarovskaia; Dilip Moonka; Nezam Afdhal
Journal:  Gastroenterology       Date:  2014-09-28       Impact factor: 22.682

2.  The association between hepatitis C infection and survival after orthotopic liver transplantation.

Authors:  Lisa M Forman; James D Lewis; Jesse A Berlin; Harold I Feldman; Michael R Lucey
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

3.  Hepatitis C virus kinetics during and immediately after liver transplantation.

Authors:  Montserrat Garcia-Retortillo; Xavier Forns; Anna Feliu; Eduardo Moitinho; Josep Costa; Miquel Navasa; Antoni Rimola; Juan Rodes
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

Review 4.  Directly acting antivirals (DAAs) for the treatment of chronic hepatitis C virus infection in liver transplant patients: "a flood of opportunity".

Authors:  E J Gane; K Agarwal
Journal:  Am J Transplant       Date:  2014-04-14       Impact factor: 8.086

5.  Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen.

Authors:  Martina Gambato; Sofía Pérez-Del-Pulgar; Charlotte Hedskog; Evguenia S Svarovskia; Diana Brainard; Jill Denning; Michael P Curry; Michael Charlton; Noelia Caro-Pérez; Maria Carlota Londoño; George Koutsoudakis; Xavier Forns
Journal:  Gastroenterology       Date:  2016-07-01       Impact factor: 22.682

6.  Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.

Authors:  Bruno Roche; Mylene Sebagh; Maria Laura Canfora; Teresa Antonini; Anne-Marie Roque-Afonso; Valerie Delvart; Faouzi Saliba; Jean-Charles Duclos-Vallee; Denis Castaing; Didier Samuel
Journal:  Liver Transpl       Date:  2008-12       Impact factor: 5.799

7.  Host cell mTORC1 is required for HCV RNA replication.

Authors:  Stefanie Stöhr; Rui Costa; Lisa Sandmann; Sandra Westhaus; Stephanie Pfaender; Eva Dazert; Philip Meuleman; Florian W R Vondran; Michael P Manns; Eike Steinmann; Thomas von Hahn; Sandra Ciesek
Journal:  Gut       Date:  2015-08-14       Impact factor: 23.059
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.